Safety of tranexamic acid in patients with stage III melanoma undergoing lymph node dissection: a retrospective cohort study

Melanoma and Skin Cancer

Effect of Anatomical Site on Prognosis and Progression Pattern in Early-Stage Acral Melanoma: A Retrospective Cohort Study of 281 Cases

J Am Acad Dermatol

Choi ME, Jung JM, Won CH, Chang SE, Lee MW, Lee WJ

doi: 10.1016/j.jaad.2025.10.065

Melanoma and Skin Cancer

Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: A nationwide real-life study in France (NEOMEL)

Br J Dermatol

Nardin C, Cavalieri C, Lebbé C, Gérard E, Puyraveau M, Vergara R, Maubec E, Kramkimel N, Lesage C, Rouanet J, Bonniaud B, Puzenat E, Popescu D, Baroudjian B, Le Corre Y, Saiag P, Brunet Possenti F, Saint-Jean M, Montaudié H, Amini-Adle M, Belkaid S, Grange F, Mansard S, Béjar CL, Darras S, Pages C, Tournier E, Funck-Brentano E, Aubin F

doi: 10.1093/bjd/ljaf268

Melanoma and Skin Cancer

Impact of the COVID-19 pandemic on melanoma: A retrospective study from the French clinical database of melanoma patients (RIC-Mel)

Ann Dermatol Venereol

Skowron F, Mouret S, Seigneurin A, Montaudié H, Maubec E, Grange F, Quereux G, Célérier P, Amini-Adle M, Dalac-Rat S, De Quatrebarbes J, Zehou O, Safia A, Muller P, Modiano P, Misery L, Litrowski N, Brunet-Possenti F, Mortier L, Bens G, Hervieu A, Leduc N, Jouary T, Lesage C, Beneton N, Le Corre Y, Geoffrois L, Thomas-Beaulieu D, Hainaut E, Charles J, Leccia MT

doi: 10.1016/j.annder.2025.103418

Melanoma and Skin Cancer

Tumor necrosis alpha inhibitor therapy is associated with increased long-term risk of non-melanoma skin cancer and melanoma: a retrospective cohort study

J Am Acad Dermatol

Driscoll CB, Schwab G, Quan VL, McKenney J, Hooper MJ, Shankar Ramesh Kumar SK, Kundu RV, Kundu SD

doi: 10.1016/j.jaad.2026.02.035

Melanoma and Skin Cancer

Sex disparities in melanoma stage, recurrence and mortality: A Danish cohort study, 2004 to 2024

J Eur Acad Dermatol Venereol

Lyngstrand JE, Røssell EL, Bønnelykke-Behrndtz ML, Laurberg T

doi: 10.1111/jdv.70180

Melanoma and Skin Cancer

Enhanced overall and progression-free survival in advanced melanoma patients undergoing targeted therapy alongside antithrombotic treatment - Insights from a multicenter study involving 1296 patients from the prospective skin cancer registry ADOReg

Eur J Cancer

Zimmermann N, Kött J, Zell T, Abedini AZ, Blomen CL, Belz S, Deitert B, Heidrich I, Geidel G, Rünger A, Smit DJ, Weichenthal M, Ugurel S, Leiter U, Berking C, Gutzmer R, Schadendorf D, von Wasielewski I, Mohr P, Meier F, Herbst R, Utikal J, Terheyden P, Haferkamp S, Pföhler C, Kaatz M, Ziller F, Ulrich J, Meiss F, Bauer AT, Schneider SW, Gebhardt C

doi: 10.1016/j.ejca.2025.116195

Melanoma and Skin Cancer

Determinants of adjuvant treatment choice between immunotherapy (immune checkpoint inhibitor) and targeted therapy in resected stage III BRAF V600-mutated cutaneous melanoma: a multicenter observational study: MELADJ3

Melanoma Res

Devoldere A, Bouche O, Barbe C, Didier K, Colbach S, Brocard FG, Carlier C

doi: 10.1097/CMR.0000000000001083

Melanoma and Skin Cancer

A national cohort study of melanoma BRAF status, testing patterns, patient and tumour characteristics, treatment and survival in England 2016-21

Br J Dermatol

Mistry K, Jeffrey P, Levell NJ, Kennedy O, Richardson K, Craig P, Bright C, Taylor S, Ragan J, Karponis D, Pethick J, Lavelle K, McRonald F, Hardy S, Vernon S, Lorigan P, Venables ZC

doi: 10.1093/bjd/ljaf351

Melanoma and Skin Cancer

The impact of the time-of-day in the administration of immunotherapy and its efficacy in patients with advanced melanoma: A retrospective observational study

Ann Dermatol Venereol

Amici M, Neveu E, Poizeau F, Edeline J, Lesimple T, Oger E, Danton G, Dupuy A, Fouchard M

doi: 10.1016/j.annder.2025.103371

Related content

Effect of Anatomical Site on Prognosis and Progression Pattern in Early-Stage Acral Melanoma: A Retrospective Cohort Study of 281 Cases

Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: A nationwide real-life study in France (NEOMEL)

Impact of the COVID-19 pandemic on melanoma: A retrospective study from the French clinical database of melanoma patients (RIC-Mel)

Tumor necrosis alpha inhibitor therapy is associated with increased long-term risk of non-melanoma skin cancer and melanoma: a retrospective cohort study

Sex disparities in melanoma stage, recurrence and mortality: A Danish cohort study, 2004 to 2024

Enhanced overall and progression-free survival in advanced melanoma patients undergoing targeted therapy alongside antithrombotic treatment - Insights from a multicenter study involving 1296 patients from the prospective skin cancer registry ADOReg

Determinants of adjuvant treatment choice between immunotherapy (immune checkpoint inhibitor) and targeted therapy in resected stage III BRAF V600-mutated cutaneous melanoma: a multicenter observational study: MELADJ3

A national cohort study of melanoma BRAF status, testing patterns, patient and tumour characteristics, treatment and survival in England 2016-21

The impact of the time-of-day in the administration of immunotherapy and its efficacy in patients with advanced melanoma: A retrospective observational study